Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to $0.06.

  • Niagen Bioscience's EPS (Basic) rose 20000.0% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.27, marking a year-over-year increase of 260000.0%. This contributed to the annual value of $0.11 for FY2024, which is 27099.43% up from last year.
  • Niagen Bioscience's EPS (Basic) amounted to $0.06 in Q3 2025, which was up 20000.0% from $0.05 recorded in Q2 2025.
  • Niagen Bioscience's EPS (Basic)'s 5-year high stood at $0.09 during Q4 2024, with a 5-year trough of -$0.13 in Q3 2021.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.01 (2022), whereas its average is -$0.02.
  • As far as peak fluctuations go, Niagen Bioscience's EPS (Basic) plummeted by 8571.43% in 2021, and later skyrocketed by 2528633.33% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's EPS (Basic) stood at -$0.08 in 2021, then surged by 73.87% to -$0.02 in 2022, then soared by 107.34% to $0.0 in 2023, then surged by 6119.08% to $0.09 in 2024, then crashed by 36.54% to $0.06 in 2025.
  • Its EPS (Basic) stands at $0.06 for Q3 2025, versus $0.05 for Q2 2025 and $0.07 for Q1 2025.